Evidence map›Paper›PMID 42888219›Full record

ArticleEuropean journal of human genetics : EJHG2026

RNA sequencing significantly improves HYDIN diagnosis and defines the effects of common deletions in primary ciliary dyskinesia.

Carolina Jaramillo Oquendo, Janice Coles, Lee Baker, David J Bunyan, N Simon Thomas, James Thompson, Gemma Fryatt, Sajida Khan, David Hunt, John W Holloway and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Carolina Jaramillo OquendoClinical and Experimental Sciences Academic Unit, University of Southampton Faculty of Medicine, Southampton, UK.
Janice ColesClinical and Experimental Sciences Academic Unit, University of Southampton Faculty of Medicine, Southampton, UK.
Lee BakerClinical and Experimental Sciences Academic Unit, University of Southampton Faculty of Medicine, Southampton, UK.ORCID http://orcid.org/0009-0001-9445-1886
David J BunyanWessex Genomics Laboratory Service, Salisbury District Hospital, Salisbury, UK.ORCID http://orcid.org/0000-0001-8686-558X
N Simon ThomasWessex Genomics Laboratory Service, Salisbury District Hospital, Salisbury, UK.
James ThompsonPrimary Ciliary Dyskinesia Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.ORCID http://orcid.org/0000-0002-9285-1317
Gemma FryattClinical and Experimental Sciences Academic Unit, University of Southampton Faculty of Medicine, Southampton, UK.
Sajida KhanClinical and Experimental Sciences Academic Unit, University of Southampton Faculty of Medicine, Southampton, UK.
David HuntWessex Clinical Genetics Service, Princess Anne Hospital, University Hospital Southampton NHS Trust, Southampton, UK.
John W HollowayHuman Development and Health, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0001-9998-0464
Jane S LucasClinical and Experimental Sciences Academic Unit, University of Southampton Faculty of Medicine, Southampton, UK.ORCID http://orcid.org/0000-0001-8701-9975
Diana BaralleHuman Development and Health, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0003-3217-4833
Woolf T WalkerPrimary Ciliary Dyskinesia Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Claire L JacksonClinical and Experimental Sciences Academic Unit, University of Southampton Faculty of Medicine, Southampton, UK. C.L.JACKSON@soton.ac.uk.ORCID http://orcid.org/0000-0002-1200-0935

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary Ciliary Dyskinesia (PCD) is a rare genetic disorder affecting ~1:7500 individuals characterised by recurrent chronic respiratory infections, bronchiectasis, laterality defects, and infertility. While at least 60 PCD-causing genes are reported, approximately 30% of patients remain without a confirmed molecular diagnosis. PCD caused by biallelic HYDIN variants is difficult to diagnose due to a 98% homologous pseudogene (HYDIN2). Additionally, functional ciliary diagnostic testing can be inconclusive due to the lack of discernible HYDIN ciliary ultrastructure defects by electron microscopy. Our aim was to diagnose genetically unresolved PCD patients with strong clinical suspicion of HYDIN defects using RNA sequencing (RNA-seq). RNA-seq was performed on total RNA extracted from patients' nasal epithelium cultured for 21 days at the air-liquid interface. Splicing abnormalities were detected using rMATS and genome-aligned reads were manually inspected using Integrative Genome Viewer. Thirteen individuals had strong clinical suspicion of PCD, normal TEM and inconclusive genetics: 11/13 had a single pathogenic or likely pathogenic variant in HYDIN, 1/13 had no variants, and 1/13 required clarification of variant origin (HYDIN vs HYDIN2). RNA-seq resolved 11/13 (85%) of cases. The same complex pathogenic aberrant splicing events were seen in seven unrelated patients. This abnormal splice pattern was caused by a large 10-kilobase deletion spanning intron 17 to intron 18. RNA-seq increases the diagnostic yield for patients with suspected PCD and has exposed a HYDIN 'hotspot' variant, increasing the observed prevalence of HYDIN-related cases within our genetically diagnosed cohort. Routine PCD genomics testing will now incorporate investigation of this genetic region of HYDIN.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.